Allianz Asset Management Gmb H Amphastar Pharmaceuticals, Inc. Transaction History
Allianz Asset Management Gmb H
- $72.3 Billion
- Q4 2024
A detailed history of Allianz Asset Management Gmb H transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Allianz Asset Management Gmb H holds 6,700 shares of AMPH stock, worth $223,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,700
Previous 6,700
-0.0%
Holding current value
$223,713
Previous $325,000
23.69%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding AMPH
# of Institutions
280Shares Held
36.7MCall Options Held
74.3KPut Options Held
22.3K-
Black Rock Inc. New York, NY5.94MShares$198 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.71MShares$90.5 Million0.0% of portfolio
-
Td Asset Management Inc2.14MShares$71.3 Million0.1% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.95MShares$65 Million0.22% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$53.9 Million0.06% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.64B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...